130 related articles for article (PubMed ID: 9536461)
21. The effects of hydergine on the MAO activity of the aged and adult rat brain.
Büyüköztürk A; Kanit L; Ersöz B; Menteş G; Hariri NI
Eur Neuropsychopharmacol; 1995 Dec; 5(4):527-9. PubMed ID: 8998407
[TBL] [Abstract][Full Text] [Related]
22. MAO-B inhibition in rabbit tissues and in human platelets by Ro 19-6327 shows similar time-course.
Kettler R; Cesura AM; Dingemanse J; Da Prada M
J Neural Transm Suppl; 1990; 32():211-4. PubMed ID: 2089093
[TBL] [Abstract][Full Text] [Related]
23. [3H]harman binding experiments. II: Regional and subcellular distribution of specific [3H]harman binding and monoamine oxidase subtypes A and B activity in marmoset and rat.
May T; Pawlik M; Rommelspacher H
J Neurochem; 1991 Feb; 56(2):500-8. PubMed ID: 1988553
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of monoamine oxidase within monoaminergic neurons in the rat brain by (E)-beta-fluoromethylene-m-tyrosine (MDL 72394).
Fagervall I; Ross SB
J Neurochem; 1989 Feb; 52(2):467-71. PubMed ID: 2521360
[TBL] [Abstract][Full Text] [Related]
25. Monoamine oxidase-inhibiting properties of SR 95191, a new pyridazine derivative, in the rat: evidence for selective and reversible inhibition of monoamine oxidase type A in vivo but not in vitro.
Kan JP; Steinberg R; Leclercq J; Worms P; Biziere K
J Neurochem; 1988 Apr; 50(4):1137-44. PubMed ID: 3346672
[TBL] [Abstract][Full Text] [Related]
26. Characterization of interactions of methylmercury with Ca2+ channels in synaptosomes and pheochromocytoma cells: radiotracer flux and binding studies.
Shafer TJ; Contreras ML; Atchison WD
Mol Pharmacol; 1990 Jul; 38(1):102-13. PubMed ID: 2164628
[TBL] [Abstract][Full Text] [Related]
27. Styrene inhibits monoamine oxidase A, but not monoamine oxidase B in monkey brain mitochondria.
Egashira T; Takayama F; Sakai K; Yamanaka Y
Toxicol Lett; 2000 Sep; 117(1-2):115-9. PubMed ID: 11033241
[TBL] [Abstract][Full Text] [Related]
28. Formation of the neurotransmitter glycine from the anticonvulsant milacemide is mediated by brain monoamine oxidase B.
Janssens de Varebeke P; Cavalier R; David-Remacle M; Youdim MB
J Neurochem; 1988 Apr; 50(4):1011-6. PubMed ID: 3346666
[TBL] [Abstract][Full Text] [Related]
29. Intra- and extra-dopamine-synaptosomal localization of monoamine oxidase in striatal homogenates from four species.
Stenström A; Hardy J; Oreland L
Biochem Pharmacol; 1987 Sep; 36(18):2931-5. PubMed ID: 3632718
[TBL] [Abstract][Full Text] [Related]
30. The properties of B-form monoamine oxidase in mitochondria from monkey platelet.
Obata T; Aomine M
Res Commun Mol Pathol Pharmacol; 2009-2010; 122-123(1-6):13-26. PubMed ID: 22032088
[TBL] [Abstract][Full Text] [Related]
31. Methylmercury-induced changes in mitochondrial function in striatal synaptosomes are calcium-dependent and ROS-independent.
Dreiem A; Seegal RF
Neurotoxicology; 2007 Jul; 28(4):720-6. PubMed ID: 17442395
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effects of ethaverine, a homologue of papaverine, on monoamine oxidase activity in mouse brain.
Lee SS; Lee JJ; Cheong MJ; Kim YH; Kim Y; Yun YP; Lee CK; Lee MK
Biol Pharm Bull; 2001 Jul; 24(7):838-40. PubMed ID: 11456127
[TBL] [Abstract][Full Text] [Related]
33. E2011 a novel, selective and reversible inhibitor of monoamine oxidase type A.
Kagaya T; Kajiwara A; Nagato S; Akasaka K; Kubota A
J Pharmacol Exp Ther; 1996 Jul; 278(1):243-51. PubMed ID: 8764357
[TBL] [Abstract][Full Text] [Related]
34. Effect of neurocatin on the activity of monoamine oxidase B in rat brain synaptosomes.
Murphy S; Pastuszko A
Neurochem Res; 1994 Feb; 19(2):177-82. PubMed ID: 8183427
[TBL] [Abstract][Full Text] [Related]
35. Low-level exposure to methylmercury modifies muscarinic cholinergic receptor binding characteristics in rat brain and lymphocytes: physiologic implications and new opportunities in biologic monitoring.
Coccini T; Randine G; Candura SM; Nappi RE; Prockop LD; Manzo L
Environ Health Perspect; 2000 Jan; 108(1):29-33. PubMed ID: 10620521
[TBL] [Abstract][Full Text] [Related]
36. Effect of moclobemide on rat brain monoamine oxidase A and B: comparison with harmaline and clorgyline.
Gerardy J
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):793-802. PubMed ID: 7938567
[TBL] [Abstract][Full Text] [Related]
37. Increased dopaminergic and 5-hydroxytryptaminergic activities in male rat brain following long-term treatment with anabolic androgenic steroids.
Thiblin I; Finn A; Ross SB; Stenfors C
Br J Pharmacol; 1999 Mar; 126(6):1301-6. PubMed ID: 10217522
[TBL] [Abstract][Full Text] [Related]
38. Intra- and extraneuronal monoamine oxidase.
Fowler CJ; Magnusson O; Ross SB
Blood Vessels; 1984; 21(3):126-31. PubMed ID: 6202347
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of mitochondrial Ca2+ release diminishes the effectiveness of methyl mercury to release acetylcholine from synaptosomes.
Levesque PC; Hare MF; Atchison WD
Toxicol Appl Pharmacol; 1992 Jul; 115(1):11-20. PubMed ID: 1378659
[TBL] [Abstract][Full Text] [Related]
40. 4-(O-benzylphenoxy)-N-methylbutylamine (bifemelane) and other 4-(O-benzylphenoxy)-N-methylalkylamines as new inhibitors of type A and B monoamine oxidase.
Naoi M; Nomura Y; Ishiki R; Suzuki H; Nagatsu T
J Neurochem; 1988 Jan; 50(1):243-7. PubMed ID: 3335842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
